The Carlyle Group and SK Capital Partners have agreed to acquire bluebird bio, Inc, a Somerville, Massachusetts-based gene therapy firm, in a take-private deal. According to terms of the agreement, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback